• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HPK1 柠檬酸基结构域调节 SLP76 的磷酸化,调节激酶结构域相互作用动态。

HPK1 citron homology domain regulates phosphorylation of SLP76 and modulates kinase domain interaction dynamics.

机构信息

Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.

Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA.

出版信息

Nat Commun. 2024 May 2;15(1):3725. doi: 10.1038/s41467-024-48014-9.

DOI:10.1038/s41467-024-48014-9
PMID:38697971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11066036/
Abstract

Hematopoietic progenitor kinase 1 (HPK1) is a negative regulator of T-cell receptor signaling and as such is an attractive target for cancer immunotherapy. Although the role of the HPK1 kinase domain (KD) has been extensively characterized, the function of its citron homology domain (CHD) remains elusive. Through a combination of structural, biochemical, and mechanistic studies, we characterize the structure-function of CHD in relationship to KD. Crystallography and hydrogen-deuterium exchange mass spectrometry reveal that CHD adopts a seven-bladed β-propellor fold that binds to KD. Mutagenesis associated with binding and functional studies show a direct correlation between domain-domain interaction and negative regulation of kinase activity. We further demonstrate that the CHD provides stability to HPK1 protein in cells as well as contributes to the docking of its substrate SLP76. Altogether, this study highlights the importance of the CHD in the direct and indirect regulation of HPK1 function.

摘要

造血祖细胞激酶 1(HPK1)是 T 细胞受体信号的负调节剂,因此是癌症免疫治疗的一个有吸引力的靶点。尽管 HPK1 激酶结构域(KD)的作用已被广泛研究,但它的柠檬酸同源结构域(CHD)的功能仍不清楚。通过结构、生化和机制研究的结合,我们描述了 CHD 与 KD 相关的结构-功能关系。晶体学和氘氢交换质谱揭示了 CHD 采用七叶β-推进器折叠结构,与 KD 结合。与结合和功能研究相关的突变显示,结构域-结构域相互作用与激酶活性的负调节之间存在直接相关性。我们进一步证明,CHD 不仅为 HPK1 蛋白在细胞内提供稳定性,还为其底物 SLP76 的对接做出贡献。总的来说,这项研究强调了 CHD 在 HPK1 功能的直接和间接调节中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/5f33003dd4f3/41467_2024_48014_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/7c867e280690/41467_2024_48014_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/750ab6ccbcfb/41467_2024_48014_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/73aa85b76491/41467_2024_48014_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/2e439128a086/41467_2024_48014_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/5f33003dd4f3/41467_2024_48014_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/7c867e280690/41467_2024_48014_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/750ab6ccbcfb/41467_2024_48014_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/73aa85b76491/41467_2024_48014_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/2e439128a086/41467_2024_48014_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b294/11066036/5f33003dd4f3/41467_2024_48014_Fig5_HTML.jpg

相似文献

1
HPK1 citron homology domain regulates phosphorylation of SLP76 and modulates kinase domain interaction dynamics.HPK1 柠檬酸基结构域调节 SLP76 的磷酸化,调节激酶结构域相互作用动态。
Nat Commun. 2024 May 2;15(1):3725. doi: 10.1038/s41467-024-48014-9.
2
Interactions between hematopoietic progenitor kinase 1 and its adaptor proteins (Review).造血祖细胞激酶 1 与其衔接蛋白之间的相互作用(综述)。
Mol Med Rep. 2017 Nov;16(5):6472-6482. doi: 10.3892/mmr.2017.7494. Epub 2017 Sep 13.
3
Functional interactions of HPK1 with adaptor proteins.HPK1与衔接蛋白的功能相互作用。
J Cell Biochem. 2005 May 1;95(1):34-44. doi: 10.1002/jcb.20401.
4
Discovery of an Allosteric, Inactive Conformation-Selective Inhibitor of Full-Length HPK1 Utilizing a Kinase Cascade Assay.利用激酶级联测定法发现全长 HPK1 的别构、无活性构象选择性抑制剂。
Biochemistry. 2021 Oct 19;60(41):3114-3124. doi: 10.1021/acs.biochem.1c00486. Epub 2021 Oct 5.
5
Design and synthesis of 1H-pyrazolo[3,4-d]pyrimidine derivatives as hematopoietic progenitor kinase 1 (HPK1) inhibitors.设计和合成 1H-吡唑并[3,4-d]嘧啶衍生物作为造血祖细胞激酶 1(HPK1)抑制剂。
Bioorg Chem. 2023 Nov;140:106811. doi: 10.1016/j.bioorg.2023.106811. Epub 2023 Aug 26.
6
B cell adaptor containing src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1.含Src同源2结构域的B细胞衔接蛋白(BASH)将B细胞受体信号传导与造血祖细胞激酶1的激活联系起来。
J Exp Med. 2001 Aug 20;194(4):529-39. doi: 10.1084/jem.194.4.529.
7
HPK1 competes with ADAP for SLP-76 binding and via Rap1 negatively affects T-cell adhesion.HPK1 与 ADAP 竞争 SLP-76 的结合,并通过 Rap1 负向影响 T 细胞黏附。
Eur J Immunol. 2010 Nov;40(11):3220-5. doi: 10.1002/eji.201040313.
8
Down-regulation of B cell receptor signaling by hematopoietic progenitor kinase 1 (HPK1)-mediated phosphorylation and ubiquitination of activated B cell linker protein (BLNK).通过造血祖细胞激酶 1(HPK1)介导的磷酸化和激活的 B 细胞连接蛋白(BLNK)的泛素化来下调 B 细胞受体信号。
J Biol Chem. 2012 Mar 30;287(14):11037-48. doi: 10.1074/jbc.M111.310946. Epub 2012 Feb 10.
9
Mona/Gads SH3C binding to hematopoietic progenitor kinase 1 (HPK1) combines an atypical SH3 binding motif, R/KXXK, with a classical PXXP motif embedded in a polyproline type II (PPII) helix.莫纳/加兹SH3C与造血祖细胞激酶1(HPK1)的结合将一个非典型的SH3结合基序R/KXXK与一个嵌入II型多聚脯氨酸(PPII)螺旋中的经典PXXP基序结合在一起。
J Biol Chem. 2004 Jul 2;279(27):28724-32. doi: 10.1074/jbc.M402745200. Epub 2004 Apr 20.
10
Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer.造血祖细胞激酶-1 结构域交换二聚体。
Structure. 2019 Jan 2;27(1):125-133.e4. doi: 10.1016/j.str.2018.10.025. Epub 2018 Nov 29.

引用本文的文献

1
An updated review of small-molecule HPK1 kinase inhibitors (2016-present).小分子HPK1激酶抑制剂的最新综述(2016年至今)。
Future Med Chem. 2024;16(22):2431-2450. doi: 10.1080/17568919.2024.2420630. Epub 2024 Nov 25.

本文引用的文献

1
Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening.通过基于结构的虚拟筛选发现新型HPK1抑制剂。
Front Pharmacol. 2022 Mar 14;13:850855. doi: 10.3389/fphar.2022.850855. eCollection 2022.
2
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8 T cell responses.TIGIT 和 PD-1 抑制途径的机制趋同需要联合阻断以优化抗肿瘤 CD8 T 细胞反应。
Immunity. 2022 Mar 8;55(3):512-526.e9. doi: 10.1016/j.immuni.2022.02.005.
3
The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for Immunotherapy.
HPK1抑制剂A-745验证了调节T细胞激酶信号用于免疫治疗的潜力。
ACS Chem Biol. 2022 Mar 18;17(3):556-566. doi: 10.1021/acschembio.1c00819. Epub 2022 Feb 21.
4
Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1).造血祖细胞激酶1(HPK1)的螺氮杂吲哚啉抑制剂的发现。
ACS Med Chem Lett. 2021 Dec 8;13(1):84-91. doi: 10.1021/acsmedchemlett.1c00473. eCollection 2022 Jan 13.
5
The citron homology domain as a scaffold for Rho1 signaling.作为 Rho1 信号传导支架的香橼同源结构域。
Proc Natl Acad Sci U S A. 2021 Sep 28;118(39). doi: 10.1073/pnas.2110298118.
6
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
7
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1.发现具有口服活性的异呋喃酮作为造血祖细胞激酶1的强效、选择性抑制剂。
ACS Med Chem Lett. 2021 Feb 19;12(3):443-450. doi: 10.1021/acsmedchemlett.0c00660. eCollection 2021 Mar 11.
8
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor.新型小分子 HPK1 抑制剂增强抗肿瘤免疫。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001402.
9
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge.二价抗体夹钳通过依赖 IgG 铰链的变构机制抑制β-胰蛋白酶。
Nat Commun. 2020 Dec 22;11(1):6435. doi: 10.1038/s41467-020-20143-x.
10
Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies.造血祖细胞激酶 1(HPK1)介导 T 细胞功能障碍,是基于 T 细胞免疫疗法的可用药靶。
Cancer Cell. 2020 Oct 12;38(4):551-566.e11. doi: 10.1016/j.ccell.2020.08.001. Epub 2020 Aug 28.